create one slide using this content

Created using ChatSlide

This presentation explores AI-driven drug discovery in Indian pharma with Dr. Reddy's Laboratories as a case study, focusing on tuberculosis treatment and the roles of AI vs humans. It delves into Indian patent law's definition of 'inventor', challenges with AI-generated patents, and implications for patent assessment. The impact on India's pharma exports, economy, and innovation is discussed, along with international comparisons and the need for legal reforms to address competitive challenges.